Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.46	19.19	15.11	11.78	42.35	21.35
Cash & Short-Term Investments	10.46	19.19	15.11	11.78	42.35	21.35
Cash Growth	34.12%	27.01%	28.26%	-72.18%	98.34%	-51.37%
Other Receivables	1.67	2.35	1.03	2.4	0	1
Receivables	1.67	2.35	1.03	2.4	0	1
Prepaid Expenses	1.28	0.48	0.99	1.85	2.48	2.06
Restricted Cash	1.35	-	-	-	1.15	-
Other Current Assets	-	-	-	0.59	-	-
Total Current Assets	14.77	22.02	17.13	16.62	45.98	24.41
Property, Plant & Equipment	-	-	-	-	22.15	21.2
Other Long-Term Assets	-	-	-	17.8	-	-
Total Assets	14.77	22.02	17.13	34.42	68.14	45.61
Accounts Payable	2.27	1.07	0.96	1.1	5.14	2.94
Accrued Expenses	0.66	2.19	1.91	1.27	3.33	2.95
Current Portion of Leases	-	-	-	-	0.62	0.39
Current Unearned Revenue	1.35	-	-	-	1.15	-
Other Current Liabilities	-	0.2	0.21	5.41	2.66	0.13
Total Current Liabilities	4.28	3.46	3.07	7.78	12.9	6.4
Long-Term Leases	-	-	-	-	11.25	11.87
Other Long-Term Liabilities	-	-	-	7.04	-	-
Total Liabilities	4.28	3.46	3.07	14.82	24.15	18.27
Common Stock	0.01	0.01	0.01	0.01	0.01	0.05
Additional Paid-In Capital	465.96	465.56	450.33	447.64	442.1	383.53
Retained Earnings	-455.48	-447.02	-436.29	-428.05	-398.12	-356.24
Shareholders' Equity	10.49	18.56	14.05	19.6	43.99	27.34
Total Liabilities & Equity	14.77	22.02	17.13	34.42	68.14	45.61
Total Debt	-	-	-	-	11.87	12.26
Net Cash (Debt)	10.46	19.19	15.11	11.78	30.48	9.1
Net Cash Growth	34.12%	27.01%	28.26%	-61.35%	235.15%	-79.05%
Net Cash Per Share	0.97	2.14	1.72	1.41	3.98	1.93
Filing Date Shares Outstanding	12.94	10.71	8.9	8.8	8.31	5.07
Total Common Shares Outstanding	11.31	10.71	8.89	8.41	8.31	5.07
Working Capital	10.49	18.56	14.05	8.84	33.08	18.01
Book Value Per Share	0.93	1.73	1.58	2.33	5.29	5.39
Tangible Book Value	10.49	18.56	14.05	19.6	43.99	27.34
Tangible Book Value Per Share	0.93	1.73	1.58	2.33	5.29	5.39
Machinery	-	-	-	-	9.66	3.87
Construction In Progress	-	-	-	-	2.23	6.79
Leasehold Improvements	-	-	-	-	3.17	0.29

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q